Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3392839 | Travel Medicine and Infectious Disease | 2015 | 6 Pages |
Abstract
In order to optimize radical cure of P. vivax, the total primaquine dose per body weight should be considered, at least 3.5Â mg/kg or even more if contracted in countries with significant drug resistance. Possibility of primaquine hepatotoxicity in chronic liver disease patients remains to be elucidated.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Shoichi Shimizu, Tadashi Kikuchi, Michiko Koga, Yasuyuki Kato, Hiroyuki Matsuoka, Haruhiko Maruyama, Mikio Kimura, Research Group on Chemotherapy of Tropical Diseases Research Group on Chemotherapy of Tropical Diseases,